BRISTOL-MYERS SQUIBB COMPANY (BMY) FY2024 Q3 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-07-01 to 2024-09-30

Swipe to see the full flow
BRISTOL-MYERS SQUIBB COMPANY cash flow reconciliation, Jul 1, 2024 through Sep 30, 2024One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net (loss)/earnings → Net cash from operating activities: $1,215,000,000.00Depreciation and amortization, net → Operating adjustments reconciliation: $2,592,000,000.00Rebates and discounts → Operating adjustments reconciliation: $1,819,000,000.00Receivables → Operating adjustments reconciliation: $661,000,000.00Acquired IPRD → Operating adjustments reconciliation: $262,000,000.00Other → Operating adjustments reconciliation: $167,000,000.00Impairment charges → Operating adjustments reconciliation: $139,000,000.00Stock-based compensation → Operating adjustments reconciliation: $129,000,000.00Other adjustments → Operating adjustments reconciliation: $103,000,000.00Operating adjustments reconciliation → Net cash from operating activities: $4,376,000,000.00Operating adjustments reconciliation → Accounts payable: $374,000,000.00Operating adjustments reconciliation → Income taxes payable: $348,000,000.00Operating adjustments reconciliation → Divestiture gains and royalties: $288,000,000.00Operating adjustments reconciliation → Deferred income taxes: $256,000,000.00Operating adjustments reconciliation → Inventories: $218,000,000.00Operating adjustments reconciliation → Equity investment (gains)/losses: $12,000,000.00Divestiture and other proceeds → investing reconciliation: $255,000,000.00Sale and maturities of marketable debt securities → investing reconciliation: $238,000,000.00investing reconciliation → Acquisition and other payments, net of cash acquired: $348,000,000.00investing reconciliation → Capital expenditures: $324,000,000.00investing reconciliation → Purchase of marketable debt securities: $40,000,000.00Net cash used in financing activities → financing reconciliation: $3,852,000,000.00Other short-term financing obligations, net → financing reconciliation: $95,000,000.00Stock option proceeds and other, net → financing reconciliation: $16,000,000.00financing reconciliation → Repayments of long-term debt: $2,478,000,000.00financing reconciliation → Dividends: $1,216,000,000.00financing reconciliation → Repayments of short-term debt obligations: $269,000,000.00Net cash used in investing activities → investing reconciliation: $219,000,000.00Exchange-rate effect → Cash sources and uses: $77,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $6,296,000,000.00Net cash from operating activities → Cash sources and uses: $5,591,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $7,893,000,000.00Cash sources and uses → Net cash used in investing activities: $219,000,000.00Cash sources and uses → Net cash used in financing activities: $3,852,000,000.00Net (loss)/earnings: $1,215,000,000.00Net (loss)/earnings+$1.22 BDepreciation and amortization, net: $2,592,000,000.00Depreciation & amortization+$2.59 BDeferred income taxes: -$256,000,000.00Deferred income taxes−$256.00 MStock-based compensation: $129,000,000.00Stock-based compensation+$129.00 MImpairment charges: $139,000,000.00Held-for-sale asset impairment+$139.00 MDivestiture gains and royalties: -$288,000,000.00Divestiture gains and royalties−$288.00 MEquity investment (gains)/losses: -$12,000,000.00Investment gain & loss−$12.00 MOther adjustments: $103,000,000.00Other non-cash items+$103.00 MReceivables: $661,000,000.00Receivables, net+$661.00 MInventories: -$218,000,000.00Inventories−$218.00 MAccounts payable: -$374,000,000.00Accounts payable−$374.00 MIncome taxes payable: -$348,000,000.00Income taxes payable−$348.00 MOther: $167,000,000.00Other working capital, net+$167.00 MAcquired IPRD: $262,000,000.00Acquired IPRD+$262.00 MRebates and discounts: $1,819,000,000.00Other accrued liabilities+$1.82 BNet cash from operating activities: $5,591,000,000.00Operating cash+$5.59 BOperating adjustments reconciliation: $5,872,000,000.00Proceeds from issuance of short-term debt obligations: $0.00Stock option proceeds and other, net: $16,000,000.00Stock option proceeds and other, net+$16.00 MProceeds from issuance of long-term debt: $0.00Dividends: -$1,216,000,000.00Dividends paid−$1.22 BOther short-term financing obligations, net: $95,000,000.00Other short-term debt issued+$95.00 MRepayments of short-term debt obligations: -$269,000,000.00Commercial paper repaid−$269.00 MRepurchase of common stock: $0.00Repayments of long-term debt: -$2,478,000,000.00Long-term debt repaid−$2.48 BNet cash used in financing activities: -$3,852,000,000.00. Cash required to fund net payments.Financing cash−$3.85 Bfinancing reconciliation: $3,963,000,000.00Sale and maturities of marketable debt securities: $238,000,000.00AFS securities proceeds+$238.00 MPurchase of marketable debt securities: -$40,000,000.00Marketable securities purchases−$40.00 MCapital expenditures: -$324,000,000.00PP&E purchases−$324.00 MDivestiture and other proceeds: $255,000,000.00Divestiture and other proceeds+$255.00 MAcquisition and other payments, net of cash acquired: -$348,000,000.00Acquisitions, net of cash−$348.00 MProceeds from sales of equity investments: $0.00Net cash used in investing activities: -$219,000,000.00. Cash required to fund net payments.Investing cash−$219.00 Minvesting reconciliation: $712,000,000.00Cash sources and uses: $11,964,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $6,296,000,000.00Beginning cash$6.30 BEnding cash: Cash, cash equivalents, and restricted cash: $7,893,000,000.00Ending cash$7.89 BExchange-rate effect: $77,000,000.00FX effect+$77.00 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$5.27 BOperating cash − cash spent on PP&ECash flow / Net income4.60×Operating cash flow ÷ net incomeNet cash change+$1.60 BEnding cash − beginning cash
Chart details

BRISTOL-MYERS SQUIBB COMPANY cash flow reconciliation, Jul 1, 2024 through Sep 30, 2024

Cash flows for Jul 1, 2024 through Sep 30, 2024. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Jun 30, 2024. Ending cash: Sep 30, 2024. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Jun 30, 2024
6,296,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
5,591,000,000 US dollars. Net cash provided.
Net (loss)/earnings
1,215,000,000 US dollars
Depreciation and amortization, net
2,592,000,000 US dollars
Deferred income taxes
negative 256,000,000 US dollars
Stock-based compensation
129,000,000 US dollars
Impairment charges
139,000,000 US dollars
Divestiture gains and royalties
negative 288,000,000 US dollars
Equity investment (gains)/losses
negative 12,000,000 US dollars
Other adjustments
103,000,000 US dollars
Receivables
661,000,000 US dollars
Inventories
negative 218,000,000 US dollars
Accounts payable
negative 374,000,000 US dollars
Income taxes payable
negative 348,000,000 US dollars
Other
167,000,000 US dollars
Acquired IPRD
262,000,000 US dollars
Rebates and discounts
1,819,000,000 US dollars
Investing activities
negative 219,000,000 US dollars. Net cash used.
Sale and maturities of marketable debt securities
238,000,000 US dollars
Purchase of marketable debt securities
negative 40,000,000 US dollars
Capital expenditures
negative 324,000,000 US dollars
Divestiture and other proceeds
255,000,000 US dollars
Acquisition and other payments, net of cash acquired
negative 348,000,000 US dollars
Proceeds from sales of equity investments
0 US dollars
Financing activities
negative 3,852,000,000 US dollars. Net cash used.
Proceeds from issuance of short-term debt obligations
0 US dollars
Stock option proceeds and other, net
16,000,000 US dollars
Proceeds from issuance of long-term debt
0 US dollars
Dividends
negative 1,216,000,000 US dollars
Other short-term financing obligations, net
95,000,000 US dollars
Repayments of short-term debt obligations
negative 269,000,000 US dollars
Repurchase of common stock
0 US dollars
Repayments of long-term debt
negative 2,478,000,000 US dollars
Operating adjustment reconciliation
5,872,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
3,963,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
712,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
77,000,000 US dollars
Ending cash on Sep 30, 2024
7,893,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
11,964,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
1,597,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
4.60×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
5,591,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
324,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
5,267,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $4.38B after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 5,591,000,000 US dollars minus 324,000,000 US dollars equals 5,267,000,000 US dollars.
BRISTOL-MYERS SQUIBB COMPANY (BMY) FY2024 Q3 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!